Hexagon Capital Partners LLC - CYTOSORBENTS CORP ownership

Quarter-by-quarter ownership
Hexagon Capital Partners LLC ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q3 2023$6,266
-47.6%
3,3330.0%0.00%
-33.3%
Q2 2023$11,965
+6.5%
3,3330.0%0.00%0.0%
Q1 2023$11,232
+117.4%
3,3330.0%0.00%
+50.0%
Q4 2022$5,166
+3.3%
3,3330.0%0.00%
+100.0%
Q3 2022$5,000
-28.6%
3,3330.0%0.00%
-50.0%
Q2 2022$7,000
-36.4%
3,3330.0%0.00%
-33.3%
Q1 2022$11,000
-21.4%
3,3330.0%0.00%
-25.0%
Q4 2021$14,000
-48.1%
3,3330.0%0.00%
-50.0%
Q3 2021$27,000
+8.0%
3,3330.0%0.01%
+14.3%
Q2 2021$25,000
-10.7%
3,3330.0%0.01%
-12.5%
Q1 2021$28,000
+7.7%
3,3330.0%0.01%0.0%
Q4 2020$26,0000.0%3,3330.0%0.01%0.0%
Q3 2020$26,0003,3330.01%
Other shareholders
CYTOSORBENTS CORP shareholders Q4 2023
NameSharesValueWeighting ↓
Skylands Capital, LLC 815,869$3,141,0000.46%
Sargent Investment Group, LLC 499,010$1,921,0000.36%
Anson Funds Management LP 74,440$287,0000.33%
One68 Global Capital, LLC 39,241$151,0000.33%
Granahan Investment Management 678,618$2,613,0000.12%
Winning Points Advisors, LLC 30,000$115,0000.07%
Avenir Corp 150,600$580,0000.06%
HighMark Wealth Management LLC 10,000$38,0000.04%
Wealthcare Advisory Partners LLC 62,279$240,0000.03%
GSA CAPITAL PARTNERS LLP 64,970$250,0000.03%
View complete list of CYTOSORBENTS CORP shareholders